Existing research on CVD risk factors among Hispanic/Latino groups in the United States has largely involved Mexican-American individuals. 2, [8] [9] [10] The few studies that have attempted to examine differences in CVD risk factors within this heterogeneous population have been limited to a few Hispanic/Latino groups 11, 12 or small sample sizes. 13, 14 This report expands the literature on Hispanic/Latino health by describing the prevalence of 5 major, readily measured biomedical CVD risk factors (high serum cholesterol and blood pressure levels, obesity, hyperglycemia/diabetes, cigarette smoking), adverse CVD risk profiles (combinations of CVD risk factors; ie, any 1 only, any 2 only, or Ն3 risk factors), and CVD (coronary heart disease [CHD] and stroke) among US Hispanic/Latino adults of diverse backgrounds. Relationships of socioeconomic status (SES), acculturation, and lifestyle factors with adverse CVD risk factor profiles and CVD were examined, and cross-sectional associations of CVD risk factors with self-reported CVD were assessed using data from the landmark Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
METHODS
The HCHS/SOL is a population-based cohort study designed to examine risk and protective factors for chronic diseases and to quantify morbidity and mortality prospectively. Details of the sampling methods and design have been published. 15, 16 Briefly, between March 2008 and June 2011, the HCHS/ SOL examined 16 415 self-identified Hispanic/Latino persons aged 18 to 74 years recruited from randomly selected households in 4 US communities (Bronx, New York; Chicago, Illinois; Miami, Florida; San Diego, California). Households were selected using a stratified 2-stage area probability sample design. 15 Census block groups were randomly selected in the defined community areas of each field center, and households were randomly selected in each sampled block group. Households were screened for eligibility, and Hispanic/Latino persons aged 18 to 74 years were selected in each household agreeing to participate. Oversampling occurred at each stage, with block groups in areas of Hispanic/Latino concentration, households associated with a Hispanic/ Latino surname, and persons aged 45 to 74 years selected at higher rates than their counterparts. Sampling weights were generated to reflect the probabilities of selection at each stage. The HCHS/SOL included participants from Cuban, Dominican, Mexican, Puerto Rican, Central American, and South American backgrounds. The study was approved by institutional review boards at each participating institution; written informed consent was obtained from all participants.
Examination Methods
Participants were asked to fast and refrain from smoking for 12 hours prior to the examination and to avoid vigorous physical activity the morning of the visit. Height was measured to the nearest centimeter and body weight to the nearest 0.1 kg. Body mass index (BMI) was calculated as weight in kilograms divided by height in meters squared. After a 5-minute rest period, 3 seated blood pressure measurements were obtained with an automatic sphygmomanometer; the second and third readings were averaged. Blood samples, including plasma glucose (fasting and after a 2-hour oral glucose load) were collected according to standardized protocols. Total serum cholesterol was measured using a cholesterol oxidase enzymatic method and high-density lipoprotein (HDL) cholesterol with a direct magnesium/dextran sulfate method. Plasma glucose was measured using a hexokinase enzymatic method (Roche Diagnostics). Low-density lipoprotein (LDL) cholesterol was calculated using the Friedewald equation. 17 Hemoglobin A 1c (HbA 1c ) was measured using a Tosoh G7 Automated HPLC Analyzer (Tosoh Bioscience).
Information was obtained by questionnaires on demographic factors, SES (education and income), acculturation (including years of residence in the United States, generational status, and language preference), cigarette smoking, physical activity (moderate/heavy intensity work and leisure activities in a typical week), and medical history. Participants were instructed to bring all prescription and nonprescription medications taken in the past month. Dietary intake was ascertained by two 24-hour dietary recalls administered 6 weeks apart. A diet score was calculated by assigning participants a score of 1 to 5 according to sex-specific quintile of daily intake of saturated fatty acids, potassium, calcium, and fiber (with 5 the most favorable quintile). The 4 scores were summed and the highest 40 percentile considered a healthier diet.
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Risk Factors, CHD, and Stroke
Major CVD risk factors were defined based on current national guidelines. Hypercholesterolemia and dyslipidemia were defined as total cholesterol 240 mg/dL or greater, LDL cholesterol 160 mg/dL or greater, or HDL cholesterol less than 40 mg/dL (for persons with and without diabetes) or receiving cholesterol-lowering medication. 19 Hypertension was a systolic blood pressure 140 mm Hg or greater, diastolic blood pressure 90 mm Hg or greater, or receiving antihypertensive medication. 20 Obesity was defined as a BMI of 30.0 or greater.
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Diabetes mellitus was a fasting plasma glucose 126 mg/dL or greater, 2-hourpostload plasma glucose 200 mg/dL or greater, an HbA 1c 6.5% or greater, or use of antihyperglycemic medications. 22 Smoking was defined as currently smoking cigarettes. (To convert total, LDL, and HDL cholesterol to mmol/L, multiply by 0.0259; to convert glucose to mmol/L, multiply by 0.0555.) Prevalent CHD was defined as selfreported history of myocardial infarction, coronary bypass surgery, balloon angioplasty, or stent placement in coronary arteries. Prevalence of stroke was ascertained from self-reported history of stroke.
Statistical Analyses
All reported values (means, prevalence, and odds ratios [ORs]) were CARDIOVASCULAR DISEASES AND HISPANICS/LATINOS IN THE UNITED STATES weighted to adjust for sampling probability and nonresponse. 15, 16 Descriptive characteristics, age-standardized to the year 2010 US population, were computed by sex and for all participants by Hispanic/Latino background. Additional analyses age-standardized to the year 2000 US population were also conducted. Mean levels and prevalence of individual risk factors, adverse CVD risk profiles (ie, presence of 0, any 1 only, any 2 only, any Ն3 risk factors), and self-reported CVD were computed by sex and by Hispanic/Latino group. Prevalence was also assessed of various combinations of risk factors, and self-reported CHD and stroke stratified by age and sex. Survey-specific procedures were used to compute 95% confidence intervals to account for the 2-stage sampling design, stratification, and clustering. Comparisons across Hispanic/Latino groups were performed using the overall Wald test.
Age-and sex-adjusted prevalence of adverse CVD risk profiles and selfreported CHD and stroke were calculated for the total cohort by age group (sex-adjusted only), sex (age-adjusted only), SES, acculturation, and lifestyle factors. Similar analyses were done for individual risk factors.
Logistic regression analyses were used to examine associations of CVD risk factors with CHD and stroke prevalence for men and women separately. Models were adjusted for age only (model 1); age plus all other major CVD risk factors (model 2); and all variables in model 2 plus education, annual family income, Hispanic/ Latino background, language preference, nativity (US-born), Short Acculturation Scale for Hispanics (SASH) score, physical activity, diet (model 3). Age, years of education, years resided in the United States, and SASH score were continuous variables, and the remaining variables were categorical. Odds ratios with 95% CIs were computed. All statistical tests were 2-sided at a significance level of .05. No adjustments were made for multiple comparisons. All analyses were performed using SAS version 9.2 (SAS Institute) and SUDAAN release 10.0.0 (RTI). Of the 16 415 HCHS/SOL participants, 772 were excluded from analyses here because of missing data on total cholesterol (n=16), BMI (n=48), cigarette smoking (n = 39), self-reported CHD (n = 19), stroke (n = 9), or other covariates (n=641). In addition, 9 participants 75 years and older and 555 participants who did not self-identify as any of the 6 aforementioned Hispanic/Latino groups were excluded. Thus, these analyses are based on data from 15 079 participants (5979 men; 9100 women).
RESULTS
Household
Participant Characteristics
Mean baseline ages standardized to year 2010 US population were similar in all Hispanic/Latino groups (range 43 tõ 44 years) (TABLE 1). About 15% of the sample had a college degree, and 37% had annual family income between $20 000 and $50 000. Approximately 51% were married or living with a partner. Seventy percent had lived in the United States for 10 or more years. Spanish was the preferred language for the majority (78%). These demographic characteristics varied across Hispanic/Latino groups. Sex-specific and other characteristics are described in eTable 1 and eTable 2 (available at http://www.jama.com).
Prevalence of Major CVD Risk Factors
The overall prevalence of hypercholesterolemia was 52% among men and ranged from 48% (Dominican and Puerto Rican men) to 55% (Central American men). In women, prevalence of hypercholesterolemia was 37% and ranged from 31% (South American women) to 41% (Puerto Rican women) (TABLE 2) .
Overall, 25% of men had hypertension; hypertension prevalence was highest among Dominican men. Hypertension prevalence overall among women was 24%. The prevalence of hypertension ranged from 16% (South American women) to 29% (Puerto Rican women) ( Table 2) .
About 37% of men were obese; prevalence of obesity ranged from 27% (South American men) to 41% (Puerto Rican men). Among women, overall prevalence of obesity was 43%. Prevalence of obesity was highest among Puerto Rican women (Table 2) .
Overall, 17% of men and women had diabetes. Prevalence ranged from 10% in South American men and women to 19% in Mexican men and women and Puerto Rican women (Table 2) .
About 26% of men were current smokers, with highest prevalence of smoking among Puerto Rican men. Overall, current smoking prevalence in women was low (15%). However, 32% of Puerto Rican women and 21% of Cuban women were current smokers ( Table 2) .
Mean levels of individual risk factors varied by Hispanic/Latino group (eTable 3 and eTable 4). For example, among men, those of Central American background had the highest mean level of total cholesterol, and those of Central and South American backgrounds had higher mean levels of LDL cholesterol compared with others. Among women, those of Cuban and Central American background had higher mean total cholesterol levels than other groups; Cuban women also had the highest average level of LDL cholesterol.
About 15% of men and women were currently using an antihypertensive medication. Use of antihypertensive medications was highest among Dominican men; in women, antihypertensive medication use was higher among those of Puerto Rican a n d D o m i n i c a n b a c k g r o u n d s . Dominican and Mexican men and Puerto Rican women had the highest rate of antihyperglycemic medication use (eTable 3 and eTable 4).
When analyses were repeated on the whole sample without exclusions other Higher sex-specific 40% of mean total physical activity. d Diet score was calculated by assigning participants a score of 1-5 according to their sex-specific quintile of daily intake of saturated fatty acids, potassium, calcium, and fiber, with 5 representing the most favorable quintile (ie, lowest quintile of intake for saturated fatty acids and highest quintile of intake for potassium, calcium, and fiber). The 4 scores were summed and the higher 40 percentile considered a healthier diet. than missing data for the major CVD risk factors, prevalences were almost identical to those in Table 2 .
Prevalence rates age-standardized to year 2000 US population were slightly lower (~1 percentage point) than rates reported earlier in this section.
CVD Risk Profiles and Self-reported CVD
Overall, 31% of men had an adverse level of any 1 major risk factor only (most commonly hypercholesterolemia); 28% and 21% had any 2 only or 3 or more risk factors (FIGURE 1) . Prevalence of 3 or more risk factors was highest among Puerto Rican men and lowest among South American men. Among women, 30% had 1 risk factor only (most commonly obesity); 23% and 17% had any 2 or 3 or more risk factors (Figure 1 ). Prevalence of 3 or more risk factors was highest among Puerto Rican women and lowest among South American women. Specific combinations of individual risk factors by sex are shown in eTable 5 and eTable 6.
The overall prevalence of CHD and stroke was, respectively, 4% and 2% for men and 2% and 1% for women. Prevalence of CHD was highest among Puerto Rican men and women and Cuban and Dominicanmen(5%);self-reportedstroke was highest for Dominican men (4%) and Puerto Rican women (2%) (eTable 7).
A significantly higher proportion of men than women, and those aged 65 to 74 years compared with younger persons had 3 or more risk factors (TABLE 3). Prevalence of 3 or more risk factors was significantly higher (PϽ.001) with lower education or income. In general, participants with lower income or education had higher rates of smoking, diabetes, obesity, and hypercholesterolemia (eTable 8). Compared with those who were less acculturated (ie, were foreign-born or firstgeneration immigrants, had lived in the United States Ͻ10 years, or for whom Spanish was the preferred language), more acculturated participants had higher prevalence of 3 or more risk factors. In sensitivity analyses excluding Puerto Rican participants (the most acculturated group who also had the highest prevalence of multiple risk factors), the magnitude of difference in prevalence of 3 or more risk factors by acculturation level was slightly lower; Prevalence, % (95% CI)
Women
Risk factors were hypercholesterolemia (serum total cholesterol Ն240 mg/dL or taking cholesterol-lowering medication), hypertension (systolic blood pressure Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg or taking antihypertensive medication), obesity (body mass index Ն30, calculated as weight in kilograms divided by height in meters squared), diabetes mellitus (use of diabetes medication, fasting glucose Ն126 mg/dL, 2-hour-postload plasma glucose Ն200 mg/dL, or hemoglobin A 1c Ն6.5%), and smoking (current cigarette smoker). Values were weighted for survey design and nonresponse and adjusted for age. Error bars indicate 95% CI. Abbreviations: CHD, coronary heart disease; CVD, cardiovascular disease; SASH, Short Acculturation Scale for Hispanics. a Prevalence by age group was adjusted for sex. Prevalence by sex was adjusted for age. The average age used for the computation was 41.02 years (overall weighted mean age). Values (except No.) were weighted for survey design and nonresponse. Model-adjusted prevalence was obtained based on multinomial logistic regression for risk factor profiles and logistic regression for CHD and stroke. b Adverse CVD risk factors were defined as follows. Hypercholesterolemia was total cholesterol Ն240 mg/dL, high-density lipoprotein cholesterol Ͻ40 mg/dL, low-density lipoprotein cholesterol Ն160 mg/dL, or receiving treatment. Hypertension was defined as systolic blood pressure Ն140 mm Hg, diastolic blood pressure Ն90 mm Hg, or receiving treatment. Obesity was defined as a body mass index Ն30, calculated as weight in kilograms divided by height in meters squared. Diabetes mellitus was defined as use of diabetes medications, fasting glucose Ն126 mg/dL, 2-hour-postload plasma glucose Ն200 mg/dL, or hemoglobin A1c Ն6.5%. Smoking was defined as currently smoking cigarettes.
(To convert total, LDL, and HDL cholesterol to mmol/L, multiply by 0.0259; to convert glucose to mmol/L, multiply by 0.0555.) c PϽ.001. d PϽ.01. e PϽ.05. f An abbreviated 10-question SASH was used; the range of scores was 1-5. Average scores Ͻ3 indicate lower acculturation and scores Ն3 indicate higher acculturation. g Higher sex-specific 40% of mean total physical activity. h Diet score was calculated by assigning participants a score of 1-5 according to their sex-specific quintile of daily intake of saturated fatty acids, potassium, calcium, and fiber, with 5 representing the most favorable quintile (ie, lowest quintile of intake for saturated fatty acids and highest quintile of intake for potassium, calcium, and fiber). The 4 scores were summed and the higher 40 percentile considered a healthy diet.
findings remained significant although level of significance was diminished. In general, more acculturated participants had markedly higher rates of current smoking and obesity compared with others. Additionally, participants with lower physical activity levels and less healthy diets had higher prevalence of 3 or more CVD risk factors. Age-and sex-adjusted prevalence of CHD and stroke were significantly higher among men, older participants (aged 65-74 years compared with younger), those who were second-or third-generation immigrants, and those who preferred English (Table 3) . Additionally, CHD prevalence was significantly higher among participants who had resided in the United States 10 or more years, and stroke prevalence was significantly higher among participants with lower family income and those born in the United States. Unweighted cell counts corresponding to weighted prevalences in eTables 1-8 are presented in eTables 9-16.
Association of CVD Risk Factors With CHD and Stroke
In age-adjusted analyses (model 1), all individual CVD risk factors were associated with higher odds of prevalent CHD (FIGURE 2); associations were especially strong for hypertension and diabetes. Associations of CVD risk factors with self-reported CHD were attenuated and in some cases lost statistical significance, with additional adjustment for other CVD risk factors (model 2) or for variables in model 3.
Associations of risk factors with prevalent stroke were less consistent (Figure 2) . In age-adjusted analyses (model 1), hypertension and diabetes mellitus were strongly associated with prevalent stroke in both sexes; high cholesterol and obesity were significantly associated and cigarette smoking was borderline significantly associated with prevalent stroke among High cholesterol was defined as serum total cholesterol level Ն240 mg/dL or taking cholesterol-lowering medication. High blood pressure was defined as systolic blood pressure Ն140 mm Hg or diastolic blood pressure Ն90 mm Hg or taking antihypertensive medication. Obesity was defined as a body mass index Ն30 (calculated as weight in kilograms divided by height in meters squared). Diabetes mellitus was defined as use of diabetes medication, fasting glucose Ն126 mg/dL, 2-hour-postload plasma glucose Ն200 mg/dL, or hemoglobin A 1c Ն6.5%. Smoking was defined as current cigarette smoker. Model 1 was adjusted for age. Model 2 was adjusted for age and all other major biomedical cardiovascular disease risk factors. Model 3 was adjusted for all variables in model 2 plus education, annual family income, Hispanic/ Latino background, language preference, nativity (US born), Short Acculturation Scale for Hispanics score, physical activity, and diet. Error bars indicate 95% CI.
women only. With further adjustment for other CVD risk factors (model 2), the association of hypertension with prevalent stroke was attenuated but remained significant in women and borderline significant in men, diabetes remained significantly associated with stroke in men, and smoking was borderline significantly associated with stroke in women only. With additional adjustment for variables in model 3, diabetes and hypertension remained positively associated with stroke among men and women, respectively. The limited available data on Hispanic/Latino people from diverse ethnic, geographic, cultural, and socioeconomic backgrounds suggest that CVD risk factor burden may vary by Hispanic/Latino origin and sociocultural characteristics. However, findings on intergroup variation in individual CVD risk factor prevalence have been inconsistent. [11] [12] [13] [14] 27 The HCHS/SOL aimed to address the gap in current knowledge on prevalence of CVD risk factors and adverse CVD risk profiles within the diverse Hispanic/Latino population and relationships of sociocultural factors and acculturation to risk factors. Baseline HCHS/SOL findings demonstrate the sizeable burden of CVD risk factors among all Hispanic/Latino groups with prevalence of risk factors comparable or higher than those reported for nonHispanic white individuals. 28, 29 The HCHS/SOL data show marked variation in CVD risk factor prevalence within the Hispanic/Latino population with some groups, particularly those of Puerto Rican background, experiencing strikingly high rates of individual adverse CVD risk factors or overall risk factor burden compared with others. For example, women of Puerto Rican background had the highest prevalence of each of the major CVD risk factors, and Mexican men and women both had high rates of diabetes. Thus, results from the HCHS/SOL suggest that previous prevalence estimates based on data primarily from Mexican American participants may have underestimated the CVD risk factor burden and diversity among US Hispanics/Latinos.
COMMENT
Studies in diverse Latin American countries have demonstrated similar variations in prevalence of CVD risk factors. The cross-sectional population-based Cardiovascular Risk Factor Multiple Evaluation in Latin America (CARMELA) study 30 examined participants from Mexico and 6 South American countries; Mexican participants had higher prevalence of obesity and diabetes compared with South American participants, consistent with findings reported here. Rates of hypertension and cigarette smoking were higher in CARMELA participants from some South American countries, in contrast to generally lower risk factor burden among South American participants in the HCHS/ SOL; these differences are likely due to differential patterns of immigration to the United States.
Among HCHS/SOL participants, major CVD risk factors were strongly associated with prevalent self-reported CVD. These findings are consistent with those reported by studies in Latin American populations such as the INTERHEART Study, ie, strong associations of CVD risk factors with risk of acute myocardial infarction. 31, 32 In other racial/ethnic groups with little or no CVD originally, migration and adoption of Western lifestyles have been associated with development of unfavorable risk factor profiles and CVD. [33] [34] [35] In the HCHS/SOL, higher degrees of acculturation by multiple proxy measures were associated with higher prevalence of multiple adverse CVD risk factors. Moreover, more acculturated participants-particularly those born in the United States-were significantly more likely to have prevalent CHD and stroke. Mexican background participants from the HCHS/SOL had higher rates of hypertension and obesity compared with those from the CARMELA study (based on similar definitions for these risk factors). 30 Thus, findings from the HCHS/SOL suggest that CVD risk status of Hispanic/Latino individuals is likely to worsen over time with increasing adoption of US lifestyles.
Findings here are limited to selfreported information on prevalent CHD and stroke (possibly biased by access to health care) and the cross-sectional nature of the data. However, the planned long-term follow-up of HCHS/ SOL participants will produce objective information on incident CVD and non-CVD outcomes. A further limitation is that the HCHS/SOL did not include any other US racial/ethnic groups for comparison. However, the data were age-standardized to the year 2000 US population to allow for comparisons with observations from national surveys, and protocols used were similar to those of other epidemiological studies.
In conclusion, findings from the HCHS/SOL demonstrate the pervasive burden of CVD risk factors in all Hispanic/Latino groups in the United States and identify specific groups by origin, sociodemographic characteristics, and sociocultural backgrounds at particularly high risk of CVD. These data may enhance the impetus to implement interventions to lower the burden of CVD risk factors among Hispanic/Latino people overall and targeted at-risk groups, as well as develop strategies to prevent future development of adverse CVD risk factors starting at the youngest ages.
